LifeStance Health Group, Inc. (LFST) P/E Ratio History
UndervaluedTrading at 74.9x vs 5Y avg 152.5x · 25th percentile · Below historical baseline · Data 2025–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, LifeStance Health Group, Inc. (LFST) trades at a price-to-earnings ratio of 74.9x, with a stock price of $13.77 and trailing twelve-month earnings per share of $0.18.
The current P/E is 51% below its 5-year average of 152.5x. Over the past five years, LFST's P/E has ranged from a low of 63.4x to a high of 357.4x, placing the current valuation at the 25th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.6x, LFST trades at a 204% premium to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.
Relative to the broader market, LFST commands a significant premium over the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our LFST DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
LFST Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
LFST P/E vs Peers
Outpatient & Specialty Clinics peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $12B | 7.9Lowest | 0.49Best | +37%Best | |
| $5B | 22.1 | - | +3% | |
| $11B | 26.9 | 1.95 | +14% | |
| $6B | 43.7 | 0.84 | -12% | |
| $358B | 22.4 | - | -15% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
LFST Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $12.03 | $0.19 | 63.4x | -58% |
| FY2026 Q2 | - | $10.71 | $0.13 | 82.6x | -46% |
| FY2026 Q1 | - | $6.37 | $0.06 | 106.7x | -30% |
| FY2025 Q4 | Dec 31 2025 | $7.04 | $0.02 | 357.4x | +134% |
Average P/E for displayed period: 152.5x
LFST Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
1+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LFST — Frequently Asked Questions
Quick answers to the most common questions about buying LFST stock.
What is LFST's P/E ratio?
LifeStance Health Group, Inc. (LFST) trailing twelve-month P/E ratio is 74.9x, based on TTM diluted EPS of $0.18. The 5-year average P/E is 152.5x and the historical range spans 63.4x to 357.4x.
Is LFST stock overvalued or undervalued?
LFST trades at 74.9x P/E, below its 5-year average of 152.5x. At the 25th percentile of its historical range (63.4x–357.4x), the stock is priced at a discount to its own history.
Is LFST stock expensive?
No, LFST is not expensive on a historical basis. The current P/E of 74.9x is below the 5-year average of 152.5x and sits at the 25th percentile of its valuation range.
What is LFST's historical P/E range?
Over the past 5 years, LFST's P/E ratio has ranged from 63.4x to 357.4x, with a median of 106.7x and an average of 152.5x. The current P/E of 74.9x places the stock at the 25th percentile of this range. Full historical data spans 2025–2026.
How does LFST's P/E compare to the S&P 500?
LFST trades at 74.9x P/E versus the S&P 500 median of 21.8x. The 244% premium to the market typically reflects higher expected earnings growth or quality.
How does LFST's valuation compare to Healthcare peers?
LifeStance Health Group, Inc. P/E of 74.9x compares to the Healthcare sector median of 24.6x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is LFST's PEG ratio?
LFST PEG ratio is N/A, based on a P/E of 74.9x and EPS growth of 113.3%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is LFST's earnings yield?
LFST earnings yield is 1.33%, the inverse of its 74.9x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.